畅脉乐胶囊临床合理用药分析
Analysis on Clinical Rational Drug Use of Changmaile Capsules
摘要: 目的:调查我院中药院内制剂畅脉乐胶囊(I)临床应用现状,为其临床合理应用提供参考。方法:采用回顾性分析,随机抽取病历100例,对其基本信息、适应症、用法用量、联合用药、不良反应等进行分析总结。结果:患者主要为老年患者,畅脉乐胶囊(I)主要用于高血压、糖尿病、脑梗死、冠心病等疾病的治疗,多与他汀类等西药联合应用;医嘱合理率为89%,不合理主要是用药与辨证不符;暂无不良反应报告。结论:畅脉乐胶囊(I)临床疗效确切,临床应用存在不合理现象,临床医生应根据患者的具体情况进行评估,规范其合理使用。
Abstract:
Objective: To investigate the clinical application status of Changmaile Capsules (I), a traditional Chinese medicine preparation in our hospital, and to provide reference for its clinical rational application. Methods: Retrospective analysis was used to randomly select 100 cases of medical records, and their basic information, indications, usage and dosage, combined medication, and adverse reactions were analyzed and summarized. Results: The patients were mainly elderly pa-tients. Changmaile Capsules (I) were mainly used for the treatment of hypertension, diabetes, cerebral infarction, coronary heart disease and other diseases, and were mostly used in combination with western medicines such as statins. The reasonable rate of doctor’s orders was 89%, which was unreasonable. The main reason is that the medication does not match the syndrome differentiation; there is no adverse reaction report. Conclusion: Changmaile Capsule (I) has definite clinical curative effect, but there are unreasonable phenomena in clinical application. Clinicians should evaluate it according to the specific conditions of patients and standardize its rational use.
参考文献
|
[1]
|
陈美华, 赵红佳, 林求诚, 等. 畅脉乐胶囊消退颈动脉粥样硬化斑块的疗效观察(附82例报告) [J]. 福建医药杂志, 2001, 23(5): 1-3.
|
|
[2]
|
陈美华, 谢胜伟. 益气活血化痰中药“畅脉乐胶囊”治疗颈动脉粥样硬化的临床研究[C]//中华中医药学会心病分会. 中华中医药学会心病分会全国第十二次学术年会暨中华中医药学会心病分会换届选举工作会议论文精选. 2010: 8.
|
|
[3]
|
林建著, 许艺惠, 黄守清. 畅脉乐胶囊对血瘀型高血压病患者血管内皮细胞分泌血栓调节蛋白的影响[J]. 福建中医药, 2015, 46(5): 47-49.
|
|
[4]
|
谢胜伟, 陈美华. 畅脉乐胶囊对颈动脉粥样硬化大鼠Wnt信号通路的影响[J]. 新中医, 2020, 52(21): 10-12.
|
|
[5]
|
翁一玲, 李煌, 卓辰茜, 刘婉婷, 陈松旺. 基于UPLC-QE-MS技术的畅脉乐胶囊化学成分分析及其抗脑血栓的网络药理学研究[J]. 中国现代药物应用, 2022, 16(21): 173-178.
|
|
[6]
|
翁一玲, 苏艺萍, 李煌, 陈松旺. 畅脉乐胶囊对MCAO大鼠脑组织保护作用研究及mGluR1、GABA_B蛋白表达的影响[J]. 福建医药杂志, 2022, 44(5): 124-127+182.
|
|
[7]
|
贾艳丽. 某中医院中成药处方分析与改进措施[J]. 中国当代医药, 2022, 29(30): 133-136.
|
|
[8]
|
涂灿, 葛斐林, 郭玉明, 张雅铭, 肖小河, 王伽伯. 何首乌相关肝损伤临床特征及用药合理性分析[J]. 中国药物警戒, 2019, 16(5): 270-276.
|
|
[9]
|
胡彦君, 钟良才, 李柏群. 医院中药制剂发展模式、合理用药及研究方向探讨[J]. 药物评价研究, 2019, 42(5): 1020-1026.
|